|
|
|
|
|
Gonadorelin Acetate |
|
C55H75N17O13 |
|
71447-49-9 |
|
It is clinically used to treat carcinoma of prostate.
|
|
Parameters of Product: 1 .Appearance :White powder 2 .Specific Optical Rotation [a]eq \o(\s\up 6(20),\s\do 2( D))20 D(c=1,1% HAc) : -55.0~-65.0¡Æ 3 .Water Content(Karl Fischer) :¡Â8.0% 4 .Acetate Content(by HPLC) :¡Â10.0% 5 .Amino Acid Composition :¡¾10% of theoretical 6 .Purity (by HPLC) :¡Ã98.0% 7 .Single Impurity(by HPLC) :¡Â1.0% 8 .Peptide Content(by %N) :¡Ã80% 9 .Assay(By Anhydrous, Acetic Acid-free ) :95.0~105.0% 10 Becterial Endotoxins :¡Â5EU/mg
|
Industrial field |
pharmaceutical |
|
|
|
|
|
|
|
There are no existing companies to distribute selected chemical product |
|
|
|
|
|